Funds holding TRANSCODE THERAPEUTICS INC
4 funds declare a position · 0 ETFs and 4 other funds · 130.7K $ · US89357L5012
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 6,545 | 56.4K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 2 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 5,783 | 57.5K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 3 | Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,180 | 11.7K $ | as of Feb 28, 2026 · Original filing | |
| 4 | Fidelity Total Market Index Fund Fidelity Concord Street Trust | 510 | 5.1K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
5 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 12,740 | 109.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 8,295 | 71.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 228 | 2K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 55 | 474 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 12 | 103 $ | as of Mar 31, 2026 |